Acute liver failure

Acute liver failure (ALF), also known as fulminant hepatic failure, refers to sudden severe liver dysfunction from injury without underlying chronic liver disease (CLD), although sometimes it presents as decompensation of unknown chronic liver disease.


Acute liver failure is rare, with <1 case per 100,000 in the developed world .

Clinical presentation

Symptoms and signs of hepatic encephalopathy and/or coagulopathy is the most common presentation.



There are many causes for acute liver failure :

Radiographic features

General features may include:

Features of cirrhosis (i.e. splenomegaly, enlarged collateral vessels, liver surface nodularity) are present in 20-30% of patients with acute liver failure (ALF), although it should be stressed that patients with ALF do not have cirrhosis .

  • early: decreased liver echogenicity (cf. right kidney)
  • late: the liver becomes heterogeneously echogenic

Vascular assessment with Doppler ultrasound is useful in determining the patency of the hepatic artery, hepatic vein, and portal vein. A diagnosis of Budd-Chiari syndrome, ischemic hepatitis, and portal vein thrombosis may be confirmed or excluded during workup.


CT may demonstrate the general imaging features along with heterogeneous enhancement on portal venous phase imaging .

Treatment and prognosis

Mortality is high in acute liver failure at ~50% (range 30-70%) with orthotopic liver transplant considered the definitive treatment . The goals of management include identification of reversible causes of acute liver failure, provide organ support to maximize the probability of recovery as well as to perform risk stratification and identify patients for consideration of early liver transplantation, as they may not survive supportive care . Consideration for transfer to a center with expertise in liver transplantation may be appropriate .